Exane Derivatives’s Macerich MAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-43
Closed -$1.86K 691
2019
Q1
$1.86K Buy
43
+11
+34% +$486 ﹤0.01% 454
2018
Q4
$1.39K Hold
32
﹤0.01% 549
2018
Q3
$1.75K Hold
32
﹤0.01% 506
2018
Q2
$1.83K Buy
32
+2
+7% +$113 ﹤0.01% 505
2018
Q1
$1.71K Sell
30
-4
-12% -$244 ﹤0.01% 456
2017
Q4
$2.23K Sell
34
-116
-77% -$7.1K ﹤0.01% 450
2017
Q3
$8.24K Buy
150
+22
+17% +$1.23K ﹤0.01% 411
2017
Q2
$7.43K Buy
128
+8
+7% +$485 ﹤0.01% 418
2017
Q1
$7.73K Buy
120
+1
+0.8% +$67 ﹤0.01% 362
2016
Q4
$8.43K Sell
119
-9,592
-99% -$685K ﹤0.01% 411
2016
Q3
$785K Buy
9,711
+4,610
+90% +$390K 0.12% 109
2016
Q2
$436K Buy
5,101
+4,998
+4,852% +$391K 0.07% 140
2016
Q1
$8.16K Hold
103
﹤0.01% 425
2015
Q4
$8.31K Hold
103
﹤0.01% 342
2015
Q3
$7.91K Buy
103
+3
+3% +$232 ﹤0.01% 361
2015
Q2
$7.46K Hold
100
﹤0.01% 377
2015
Q1
$8.43K Sell
100
-276
-73% -$24.1K ﹤0.01% 389
2014
Q4
$31.4K Buy
+376
New +$27.7K ﹤0.01% 352

Other funds holding MAC

Exane Derivatives's MAC Position: Q2 2019 in Review

Exane Derivatives sold out of Macerich (MAC) in Q2 2019, closing a stake of 43 shares — an estimated $1.86K sold.

Exane Derivatives first reported a position in MAC in Q4 2014 and held it in 18 quarters. The position peaked at $785K in Q3 2016. 317 funds tracked by Wall St. Rank hold MAC as of Q2 2019.

  • Exane Derivatives reported no remaining Macerich position as of Q2 2019 after selling out during the quarter.
  • Exane Derivatives sold 43 Macerich shares in Q2 2019, an estimated $1.86K.
  • Exane Derivatives first reported a position in Macerich in Q4 2014 and held it in 18 quarters.
  • Exane Derivatives's Macerich position peaked at $785K in Q3 2016.
  • 317 funds tracked by Wall St. Rank held Macerich as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.